Evidence map›Paper›PMID 16537603›Full record

ArticleJournal of virology2006

ICP0 is not required for efficient stress-induced reactivation of herpes simplex virus type 1 from cultured quiescently infected neuronal cells.

Craig S Miller, Robert J Danaher, Robert J Jacob

Open access · greenAbstract readComparative Study
In one paragraph

Article in Journal of virology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Trichostatin A and oncolytic HSV combination therapy shows enhanced antitumoral and antiangiogenic effects.Molecular therapy : the journal of the American Society of Gene Therapy · 2008
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Craig S MillerCenter for Oral Health Research, University of Kentucky College of Dentistry, Lexington, KY 40536-0297, USA. cmiller@uky.edu
Robert J Danaher
Robert J Jacob
University of Kentucky · US

Funding

Opportunistic Oral HSV-- Mechanisms of ReactivationR01DE014142 · NIDCR · UNIVERSITY OF KENTUCKY · PI MILLER, CRAIG S · 2001 to 2006
$1.4M
NIDCR NIH HHS DE014142NIDCR NIH HHS R01 DE014142
6 · The paper itself

Abstract

Viral genes sufficient and required for herpes simplex virus type 1 (HSV-1) reactivation were identified using neuronally differentiated PC12 cells (ND-PC12 cells) in which quiescent infections with wild-type and recombinant strains were established. In this model, the expression of ICP0, VP16, and ICP4 from adenovirus vectors was sufficient to reactivate strains 17+ and KOS. The transactivators induced similar levels of reactivation with KOS; however, 17+ responded more efficiently to ICP0. To identify viral transactivators required for reactivation, we examined quiescently infected PC12 cell cultures (QIF-PC12 cell cultures) established with HSV-1 deletion mutants R7910 (deltaICP0), KD6 (deltaICP4), and in1814, a virus containing an insertion mutation in VP16. Although growth of these mutant viruses was impaired in ND-PC12 cells, R7910 and in1814 reactivated at levels equivalent to or better than their respective parental controls following stress (i.e., heat or forskolin) treatment. After treatment with trichostatin A, in1814 and 17+ reactivated efficiently, whereas the F strain and R7910 reactivated inefficiently. In contrast, KD6 failed to reactivate. In experiments with the recombinant KM100, which contains the in1814 mutation in VP16 and the n212 mutation in ICP0, spontaneous and stress-induced reactivation was observed. However, two strains, V422 and KM110, which lack the acidic activation domain of VP16, did not reactivate above low spontaneous levels after stress. These results demonstrate that in QIF-PC12 cells ICP0 is not required for efficient reactivation of HSV-1, the acidic activation domain of VP16 is essential for stress-induced HSV-1 reactivation, and HSV-1 reactivation is modulated uniquely by different treatment constraints and phenotypes.

Indexed as

Virus ActivationAcyclovirAdenoviridaeAnimalsAntimetabolitesCell Culture TechniquesCell DifferentiationCells, CulturedChlorocebus aethiopsHerpes Simplex Virus Protein Vmw65Herpesvirus 1, HumanHumansImmediate-Early ProteinsKineticsNeuronsPC12 CellsAcyclovirAntimetabolitesHerpes Simplex Virus Protein Vmw65herpes simplex virus, type 1 protein ICP4Immediate-Early ProteinsUbiquitin-Protein LigasesVmw110 protein, Human herpesvirus 1

Identifiers

PMID16537603
PMCPMC1440419
OpenAlexW2007430051

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.